Annual net result of Genmab 2009-2019

This statistic shows the annual net result of the Danish biotechnology company Genmab from 2009 to 2019. The company's net results were negative from 2009 to 2012, but turned positive in 2013. The annual net results were increasing from 2013 and peaked in 2019 at a value of around 2.2 billion Danish kroner.

Annual net result of Genmab from 2009 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020



Survey time period

2009 to 2019

Supplementary notes

Genmab is a Danish biotechnology company founded in 1999. The company is specializing in therapeutics for cancer treatment.

Some figures has been taken from previous publications.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Biotechnology in Germany"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.